https://www.selleckchem.com/products/mirdametinib-pd0325901-mek-inhibitor.html
PD0325901 (Mirdametinib) | MEK Inhibitor | CAS 391210-10-9 | Selleck Chemicals
PD0325901 is MEK inhibitor and non-competitive with ATP, Kiapp of 1 nM against activated MEK1 and MEK2. Find all the information about PD0325901 for cell...
mirdametinibmekinhibitorcaschemicals
https://www.selleckchem.nl/products/mirdametinib-pd0325901-mek-inhibitor.html
PD0325901 (Mirdametinib) | MEK Remmer | Op voorraad in Nederland | Selleck Nederland
Mirdametinib (PD0325901) is een selectieve en niet-ATP-competitieve MEK-remmer met een IC50 van 0,33 nM in celvrije assays, ruwweg 500-maal potenter dan...
op voorraadin nederlandmirdametinibmek
https://hollywoodsblackrenaissance.com/
PD0325901 (Mirdametinib) Hollywood's Black Renaissance - Hollywood's Black Renaissance
Hollywood’s Black Renaissance is a digital platform dedicated to highlighting the achievements and successes of women of the African diaspora who work in film...
mirdametinibhollywoodblackrenaissance
https://www.selleck.kr/products/mirdametinib-pd0325901-mek-inhibitor.html
PD0325901 (Mirdametinib) | MEK inhibitor | MEK Inhibitor | 국내 재고 보유 | Selleck 한국 (Selleck Korea)
Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM in cell-free assays, roughly 500-fold more potent than...
mirdametinibmekinhibitorkorea
https://www.gomekli.com/
GOMEKLI® (mirdametinib) for Neurofibromatosis Type 1 with PN
GOMEKLI® (mirdametinib) is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have...
mirdametinibneurofibromatosistypepn
https://investornewsupdates.com/article/815837234-springworks-therapeutics-krijgt-positief-advies-van-de-chmp-voor-mirdametinib-voor-de-behandeling-van-volwassen-en-pediatrische-pati-nten-met-nf1-pn
SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling...
springworkstherapeuticspositiefadvies